موافقات الدواء

First-Line Maintenance Treatment of Advanced Ovarian Cancer
Niraparib is indicated for the maintenance treatment of adult patients with
advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial response to first-line platinum-based chemotherapy.
- Maintenance Treatment of Recurrent Germline BRCA-mutated Ovarian Cancer
Niraparib is indicated for the maintenance treatment of adult patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAmut)
recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial response to platinum-based chemotherapy.
A test is used by Your healthcare provider to determine whether you have BRCA mutated ovarian cancer